15044-1-0706.qxp

For the most up-to-date Primary/Preferred Drug List visit www.caremark.com
The Caremark Primary/Preferred Drug List is a guide within select therapeutic categories for clients and their plan participants.
Generics should be considered the first line of prescribing. If there is no generic available, there may be more than one brand
name medicine to treat a condition. These preferred brand name medicines are listed to help identify products that are clinically
appropriate and cost-effective.
PLAN PARTICIPANT
HEALTHCARE PROVIDER
Your benefit plan provides you with a prescription benefit program Your patient is covered under a prescription benefit plan administered by administered by Caremark. Ask your doctor to consider prescribing, when Caremark. As a way to help manage healthcare costs, authorize generic medically appropriate, a preferred medicine from this list. Take this list substitution whenever possible. If you believe a brand name product is along when you or a covered family member sees a doctor.
necessary, consider prescribing a brand name on this list.
Please note:
Please note:
■ Your specific prescription benefit plan design may not cover certain ■ Generics should be considered the first line of prescribing.
categories, regardless of their appearance in this document.
■ This drug list is not inclusive nor does it guarantee coverage, but ■ For specific information regarding your prescription benefit coverage and represents a summary of prescription coverage.
co-pay1 information, please visit our Web site at www.caremark.com,
■ The plan participant’s specific prescription benefit plan may have or contact a Caremark Customer Care representative.
a different co-pay1 for specific products on the list.
■ Caremark may contact your doctor after receiving your prescription to ■ Unless specifically indicated, drug list products will include all request consideration of a drug list product or generic equivalent. This may result in your doctor prescribing, when medically appropriate, a ■ Log in to www.caremark.com to check coverage and co-payments1
different brand name product or generic equivalent in place of your § NUCLEOSIDE
PROTEASE INHIBITORS
AROMATASE INHIBITORS
REVERSE-TRANSCRIPTASE
ANTIBACTERIALS
INHIBITORS
ALKYLATING AGENTS
§ CEPHALOSPORINS
LUTEINIZING
§ ERYTHROMYCINS/
HORMONE-RELEASING
MACROLIDES
HORMONE (LHRH)
AGONISTS
ANTIMETABOLITES
§ FLUOROQUINOLONES
NUCLEOSIDE
REVERSE-TRANSCRIPTASE
ANTIVIRALS
INHIBITOR COMBINATIONS
MISCELLANEOUS AGENTS
§ CYTOMEGALOVIRUS
§ ACE INHIBITORS
§ ANTIFUNGALS
§ HEPATITIS AGENTS
ACE INHIBITOR/CALCIUM
CHANNEL BLOCKERS
ANTIRETROVIRALS
NUCLEOTIDE
REVERSE-TRANSCRIPTASE
FUSION INHIBITORS
TYROSINE KINASE
INHIBITORS
INHIBITORS
NON-NUCLEOSIDE
§ ADRENOLYTICS, CENTRAL
§ HERPES AGENTS
REVERSE-TRANSCRIPTASE
INHIBITORS
§ INFLUENZA AGENTS
HORMONAL
ANGIOTENSIN II
ANTINEOPLASTIC AGENTS
RECEPTOR ANTAGONISTS/
COMBINATIONS
ANTIANDROGENS
CASODEX
ANTIESTROGENS
Your specific prescription benefit plan design may not cover certain categories, regardless of their appearance in this document.
ORAL ESTROGEN/
§ ANTIARRHYTHMICS
ANTIDEMENTIA
§ PROTON PUMP
PROGESTINS
INHIBITORS
ANDROGENS
ANTILIPEMICS
ANTILIPEMIC COMBINATIONS
PROTON PUMP INHIBITORS
ANTIDIABETICS
WITH ANTI-INFECTIVE
FERTILITY REGULATORS
§ BILE ACID RESINS
ANTIDEPRESSANTS
ALPHA-GLUCOSIDASE
§ MISCELLANEOUS AGENTS
INHIBITORS
§ RECTAL STEROIDS
CHOLESTEROL ABSORPTION
INHIBITORS
MONOAMINE OXIDASE
INSULINS
INHIBITORS (MAOIs)
SALIVA STIMULANTS
§ FIBRATES
HUMAN GROWTH
HORMONES
§ HMG-CoA REDUCTASE
§ SELECTIVE SEROTONIN
INHIBITORS
REUPTAKE INHIBITORS
§ BENIGN PROSTATIC
INSULIN SENSITIZERS
HYPERPLASIA
INSULIN SENSITIZER/
SEROTONIN
ERECTILE DYSFUNCTION
BIGUANIDE COMBINATIONS
§ BETA-BLOCKERS
NOREPINEPHRINE
§ PROGESTINS
PHOSPHODIESTERASE
REUPTAKE INHIBITORS
INHIBITORS
(SNRIs) 3
INSULIN SENSITIZER/
SELECTIVE ESTROGEN
§ CALCIUM CHANNEL
SULFONYLUREA
RECEPTOR MODULATORS
BLOCKERS
COMBINATIONS
ALPROSTADIL AGENTS
§ ANTIPARKINSONIANS
MEGLITINIDES
§ THYROID SUPPLEMENTS
CALCIUM CHANNEL
§ URINARY
BLOCKER/ANTILIPEMIC
SUPPLIES
ANTISPASMODICS
COMBINATIONS
§ ANTIEMETICS
§ DIGITALIS GLYCOSIDES
ANTIPSYCHOTICS
ENDOTHELIN RECEPTOR
ANTAGONISTS
BISPHOSPHONATES
ANTIOBESITY–
§ ANTICOAGULANTS
FAT ABSORPTION
DECREASING AGENTS
NITRATES
§ ATTENTION DEFICIT
§ PLATELET AGGREGATION
SUBLINGUAL
HYPERACTIVITY
CONTRACEPTIVES
INHIBITORS
§ ANTISPASMODICS
DISORDER/NARCOLEPSY
§ MONOPHASIC
§ TRANSDERMAL
§ TRIPHASIC
§ CHOLELITHOLYTICS
IMMUNOMODULATORS
EXTENDED CYCLE
INFLAMMATORY BOWEL
INTERFERONS
§ ANTICONVULSANTS
TRANSDERMAL
§ ORAL AGENTS
MIGRAINE
SELECTIVE SEROTONIN
INTERFERON/ANTIVIRAL
AGONISTS
COMBINATIONS
ESTROGENS
§ RECTAL AGENTS
IMMUNOSUPPRESSANTS
MULTIPLE SCLEROSIS
ANTIMETABOLITES
§ LAXATIVES
§ TRANSDERMAL,
ESTROGENS
PANCREATIC ENZYMES
§ CALCINEURIN INHIBITORS
§ MUSCULOSKELETAL
THERAPY AGENTS
Your specific prescription benefit plan design may not cover certain categories, regardless of their appearance in this document.
RAPAMYCIN DERIVATIVES
§ STEROIDS
BETA-BLOCKERS, SELECTIVE
§ BETA AGONISTS
DERMATOLOGY
CARBONIC ANHYDRASE
INHIBITORS
FOLIC ACID COMBINATIONS
§ MISCELLANEOUS SKIN
§ DECONGESTANT/
AND MUCOUS MEMBRANE
CARBONIC ANHYDRASE
§ PRENATAL VITAMINS
EXPECTORANTS
INHIBITOR/BETA-BLOCKERS
§ ACTINIC KERATOSIS
LEUKOTRIENE RECEPTOR
OPHTHALMIC
IMMUNOMODULATORS
§ ANTIBIOTICS
ANAPHYLAXIS TREATMENT
ANTAGONISTS
§ ANTIALLERGICS
PROSTAGLANDINS
NASAL ANTIHISTAMINES
§ ANTIFUNGALS
§ ANTI-INFECTIVE/
§ SYMPATHOMIMETICS
§ ANTICHOLINERGICS
§ NASAL STEROIDS
ANTI-INFLAMMATORIES
ANTIPSORIATICS
ANTICHOLINERGIC/
§ ANTI-INFLAMMATORIES,
ANTI-INFECTIVES
BETA AGONISTS
IMMUNOMODULATORS
STEROIDAL
STEROID/BETA AGONISTS
§ ANTI-INFECTIVE/
§ ANTI-INFLAMMATORIES,
ANTI-INFLAMMATORIES
NONSTEROIDAL
ANTIHISTAMINES,
§ LOCAL ANALGESICS
STEROID INHALANTS
LOW SEDATING
§ ROSACEA
§ BETA-BLOCKERS,
§ ANTIHISTAMINE/
NONSELECTIVE
DECONGESTANTS
§ XANTHINES
QUICK REFERENCE BRAND PRIMARY/PREFERRED DRUG LIST
Your specific prescription benefit plan design may not cover certain categories, regardless of their appearance in this document.
FOR YOUR INFORMATION: Generics should be considered the first line of prescribing. This Caremark Drug List is not inclusive nor does it guarantee coverage, but represents a
summary of prescription coverage. Specific prescription benefit plan design may not cover certain categories, regardless of their appearance in this document. The plan participant's
prescription benefit plan may have a different co-pay1 for specific products on the list. Unless otherwise indicated, drug list products will include all dosage forms. Listed products may
be available generically in certain strengths or dosage forms. Log in to www.caremark.com to check coverage and co-payments for a specific medicine.
§ Generics are available in this class and should be considered as the first line of prescribing.
1 Co-payment or co-pay means the amount a plan participant is required to pay for a prescription in accordance with a Plan, which may be a deductible, a percentage of the prescription price, a fixed amount or other charge, with the balance, if any, paid by a Plan.
2 Atacand should be reserved for patients who meet CHARM (Candesartan in Heart Failure - Assessment of Reduction in Mortality and Morbidity) trial criteria.
3 Indicates the proposed mechanism of action, based on the American Psychiatric Association Summary of Treatment Recommendations.
4 Higher co-payments may apply depending on the plan participant's specific prescription benefit plan. Log in to www.caremark.com to find the co-payment under a specific plan.
5 An Accu-Chek or OneTouch blood glucose meter will be provided at no charge by the manufacturer to those individuals currently using a meter other than Accu-Chek or OneTouch.
For more information on how to obtain a blood glucose meter, call toll-free: 1-800-588-4456.
Your privacy is important to us. Our employees are trained regarding the appropriate way to handle your private health information.
Caremark may receive rebates, discounts and service fees from pharmaceutical manufacturers for certain listed products.
This Caremark Drug List contains prescription brand name medicines that are registered or trademarks of pharmaceutical manufacturers that are not affiliated with Caremark Inc.
Listed products are for informational purposes only and are not intended to replace the clinical judgment of the prescriber.
2006 Caremark Inc. All rights reserved.
www.caremark.com

Source: http://familyhealthofdelaware.com/files/Primary_Preferred_DL_2006.pdf

xingyibio.com.tw2

Amersham Interleukin-1 Beta [(h)IL-1β] Human, Biotrak ELISA System 1. LegalGE, imagination at work and GE monogram are trademarks of General Electric Company. Amersham and Biotrak are trademarks of GE Healthcare companies. © 1995–2009 General Electric Company – All rights reserved. First published 1995. All goods and services are sold subject to the terms and conditions of sale of the co

Microsoft word - pre-anestheticform.doc

Please fill out this form carefully and completely. Pasadena Surgery Center Bring to Pasadena Surgery Center on the day of surgery. Patient Name: _____________________________ Pro cedure # 1: ____________________________________________ Height: _____________ Weight: ______________ Pro cedure # 2: _________________________________ Are you allergic to latex?

Copyright ©2018 Drugstore Pdf Search